GENinCode UK Ltd. (9PL) AI Stock Analysis

GENinCode UK Ltd.

(Frankfurt:9PL)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue Growth and Gross MarginAccelerating revenue and improving gross margin indicate better commercial traction and unit economics. If maintained, this combination can expand the company’s ability to fund operations internally, support investment in its diagnostics platform, and improve operating leverage as scale increases.

Negative Factors

Deep and Persistent UnprofitabilityLarge and persistent losses show that the current cost base remains far above the revenue scale generated by the business. Without substantial operating improvement, continued losses can consume capital, restrict strategic investment, and delay any credible path to sustainable earnings.

GENinCode UK Ltd. (9PL) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 4.97M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.5
Beta (1Y): 13.27
Revenue Growth: -13.75%
EPS Growth: 44.57%
Country: Germany
Employees: 44
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Diagnostics & Research

GENinCode UK Ltd. Business Overview & Revenue Model

Company Description

GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology...

GENinCode UK Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:9PL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:GDR	49Neutral	GBP 15.65M	-0.89	-1044.57%	―	65.60%	74.84%
GB:CLBX	48Neutral	GBP 6.82M	-0.49	-104.73%	―	-56.10%	41.10%
GB:ABDX	46Neutral	GBP 22.75M	-16.36	-34.31%	―	30.42%	43.16%
GB:OBD	40Underperform	GBP 14.45M	-0.27	-451.74%	―	33.37%	86.41%
GB:RENX	40Underperform	GBP 36.54M	-3.44	675.00%	―	―	―

* Healthcare Sector Average

Performance Comparison

DE:9PL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:9PL	GENinCode UK Ltd.	0.01	-0.01	-56.52%
GB:CLBX	ANGLE plc	0.60	-1.95	-76.47%
GB:GDR	Genedrive plc	0.97	0.01	1.25%
GB:OBD	Oxford BioDynamics	0.11	-0.21	-66.56%
GB:RENX	Renalytix Plc OTC	5.45	-1.93	-26.15%
GB:ABDX	Abingdon Health PLC	9.00	2.75	44.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

GENinCode UK Ltd. AI Stock Analysis